Homemultiple sclerosis

  • Atrophied Brain Lesion Volume could be a new biomarker for Progressive MS, study suggests

    • June 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Ph 2 data for Ublituximab shows encouraging efficacy results in RMS patients

    • June 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Recent study investigated RRMS to SPMS progression in MS patients

    • June 1, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Rituximab shows efficacy in RRMS and Progressive MS patients, recent study underlines

    • May 31, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Fingolimod, in MS patients, offers treatment satisfaction and improves Quality of life, study reinforces

    • May 27, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Stem cell based treatment investigated for SPMS

    • May 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • EMA reconfirms the low Benefit risk profile of Zinbryta

    • May 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Progression from CIS to MS to be predicted by Peripheral blood cells, research finds

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Gilenya approved by FDA for Pediatric RMS patients

    • May 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Spinal fluid can predict MS progression, claims study

    • May 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more